Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CR8020 in Influenza Challenge Model
NCT01938352Phase 2Completed
- Sponsor
- Crucell
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CR8020 in influenza, sponsored by Crucell. Started Oct 2013; status: completed.
02
Drugs
CR8020
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01938352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938352.